Nasdaq 100 Stocks SEC Filings — May 14, 2026

USA NASDAQ-100

By Gunpowder Editorial ·

19 high priority 29 medium priority 48 total filings analysed

Executive Summary

The 48 filings from NASDAQ-100 constituents and related entities reveal mixed Q1 2026 results across 15 earnings reporters, with 8/15 showing YoY revenue growth averaging +28% (e.g., ImmuCell +28%, INBS +46%, Intuitive Machines +200%), but persistent net losses in 12/15 amid rising G&A/exploration costs; margin expansions noted in 4/15 (e.g., INBS +370 bps gross margin). Key themes include accretive M&A (Iridium-Aireon adding $100M rev, Intuitive Machines-Lanteris boosting backlog to $1.1B), regulatory wins (TMC NOAA compliance by Q1 2027, INmune Bio FDA Fast Track), and institutional positioning via 13Fs favoring mining/tech (e.g., Mudita heavy in gold/mining, Paradigm in semis). Capital allocation leans conservative with dividend hikes (Applied Materials +15% to $0.53/share) but no buybacks noted; cash burns improved in 6/15 ops cash flow metrics. Portfolio-level trends show metals/biotech outperformance in milestones vs. services revenue softness (Intellinetics -8%). Forward catalysts cluster in H2 2026 (deal closes, trial data), signaling alpha in space/mining amid AI/semicon strength. Overall, bullish on strategic progress offsetting losses, with watch for cash runway in microcaps.

Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from May 06, 2026.

Investment Signals (12)

  • Q1 rev +28% YoY to $10.4M, gross margins +340 bps to 45%, net income +36% to $1.9M, FCF $3.4M, cash +79% QoQ to $6.8M

  • Iridium Communications (IRDM) (BULLISH)

    Acquiring 61% Aireon for $366.7M accretive, adds $100M ann. rev/$30M OEBITDA, 10% rev CAGR, closes early July 2026, leverage to 4.0x then normalize

  • Record Q2 FY26 rev +11% YoY to $7.91B, GAAP EPS +33% to $3.51, gross margin +80 bps to 49.9%, dividend +15% to $0.53/share, Q3 guide $8.95B rev

  • Intelligent Bio Solutions (INBS) (BULLISH)

    Q3 rev +46% YoY to $1.06M, cartridge sales +59%, gross margins +370 bps to 50.5%, 9-mo rev +39%, cash +827% QoQ to $6.9M

  • Q1 rev ~3x YoY to $186.7M, +Adj EBITDA $2.7M, backlog $1.1B post-Lanteris, FY26 guide $900M-$1B rev positive EBITDA

  • INmune Bio (INMB) (BULLISH)

    FDA Fast Track for XPro in early AD, Phase 2b/3 trial advancing with EMACC/pTau217 endpoints

  • NOAA full compliance for USA A permit by end-Q1 2027, Allseas nodule system 3M wet tonnes ann. cap. Q4 2027 commission, liquidity $164M

  • Q1 rev +11.1% YoY to $1.07B (exceeds exp.), Adj EBITDA +19.1% margin +150 bps to 21%, reaffirms FY26 5-5.3% OCC growth

  • ImmuCell (10-Q) (BULLISH)

    Ops cash flow +127% YoY to $3.57M, equity +$1.94M QoQ improvement, debt -4% QoQ

  • Welsbach (EM&T) (BULLISH)

    13 ULVAC machines expand rare earth magnet cap to 10k tons ann. by Nov 2026, largest non-China producer

  • Annual meeting all proposals >97% approval incl. comp/dirs/auditors, strong governance signal

  • Microsoft (BULLISH)

    Adds Carmine Di Sibio (ex-EY CEO) to board, expertise in risk/finance, expands to 13 members

Risk Flags (10)

  • Intellinetics (INLX) [HIGH RISK]

    Q1 rev -8% YoY to $3.9M, gross profit -12%, op loss widens to $1.18M, cash -18% QoQ to $2.1M, ops cash use +744% YoY

  • Q1 net loss improves to $3.95M but cash -37% QoQ to $6.8M, ops cash use $3.84M worse YoY, terminated Lion Energy deal

  • NIQ Global Intelligence (10-Q) [RISK]

    Q1 op loss $10.2M vs +$15.7M YoY profit, cash -$156M QoQ to $362M, ops cash use $63.6M

  • Q1 rev -8% YoY to $1.1M, swings to $4.4M net loss vs +$2.6M profit, equity -30% QoQ to $2.9M, needs funding

  • MetaVia [RISK]

    Q1 net loss widens 4% YoY to $3.8k, G&A +23.5% to $1.9M, op cash burn $4.3k though improved YoY

  • Cadiz Inc [RISK]

    Q1 rev -45% YoY to $1.6M, ops cash use worsens to $5.5M YoY, equity -33% QoQ to $15.6M despite debt raise

  • Faraday Future [HIGH RISK]

    Q1 net loss widens to $38.9M YoY, ops cash burn +55% to $31.5M, cash -65% QoQ to $12.2M

  • Q1 investment income -38% YoY to $3.4M, unrealized depr $1.5M vs +$151k YoY, no distributions vs $451k prior

  • TMC [RISK]

    Q1 op exps +89% YoY to $34M despite flat loss, G&A +144% to $20.7M

  • 5/7 directors >9.9M withheld votes at AGM, signaling dissent despite approvals

Opportunities (10)

  • Accretive deal adds $100M rev/$30M EBITDA, integrates ADS-B, partnerships to 2035, close early July 2026

  • $1.1B backlog from $800M Lanteris +$429M SDA/$180M CLPS, FY26 $900M-$1B rev, Goonhilly acquisition Q2

  • XPro for early AD accelerates devt, Phase 2b/3 trial biomarkers, targets neuroinflammation

  • NOAA permit end-Q1 2027, Allseas 3M tonnes Q4 2027, $5.5B NPV PFS reserves

  • ImmuCell/Growth (OPPORTUNITY)

    Record Q1 rev/margins/income, FCF positive, capacity expansion funded by $2M settlement

  • Record rev/EPS, ASMPT NEXX acquire, EPIC centers, Q3 $8.95B rev guide

  • NIQ/Restructuring (OPPORTUNITY)

    $70-80M ann. savings program, eComm rev +33%, 17 seven-figure wins, FY26 guide intact

  • 10k ton rare earth magnets by Nov 2026, vertically integrated, US defense buy-American Jan 2027

  • INBS/Turnaround (OPPORTUNITY)

    Rev +46% YoY, margins expand, cash surges 827% QoQ, cartridge dominance 66% rev

  • Mudita Advisors 13F (OPPORTUNITY)

    Heavy mining bets (IAMGOLD $44M, Est. Labs $43M), signals conviction in resources

Sector Themes (6)

  • Biotech/Pharma Mixed Resilience

    7/10 reporters (ImmuCell, INBS, MetaVia, Arcadia, INmune) show rev growth avg +20% or milestones (Fast Track), but losses in 6/7 widen on G&A/R&D; opportunity in regulatory catalysts vs. cash burn risks

  • Metals/Mining Progress Amid Losses

    TMC/Aqua/Western/Cadiz report op exps up 39-144% YoY but milestones (NOAA, battery-grade Li, site selection); 4/6 cash down QoQ avg -20%, institutional bets via 13Fs (Mudita gold/mining $200M+)

  • Space/Tech M&A Momentum

    Iridium/Intuitive Machines deals add $900M+ rev/backlog, backlog $1.1B+; Applied semi rev +11% YoY, signals AI/infra spend

  • Services Revenue Softness

    NIQ +11% rev/Intellinetics -8%/ImmuCell +28%; 3/5 gross margins contract avg -200 bps on mix/costs, but NIQ EBITDA +19%

  • Institutional Mining/Tech Tilt

    6/13 13Fs (Mudita, Paradigm, Camden) overweight mining (gold $100M+ positions), semis (Broadcom $250M), tech converts; neutral sentiment but conviction via sole discretion

  • Capital Discipline

    Dividend hikes (Applied +15%), no buybacks; debt raises (Cadiz $15M, Verizon $4B notes), equity issuances fund ops in microcaps

Watch List (8)

Filing Analyses (48)
TMC the metals Co Inc. 8-K mixed materiality 8/10

14-05-2026

TMC reported a Q1 2026 net loss of $20.6 million, flat YoY from $20.6 million despite higher exploration expenses of $13.3 million (up ~40% YoY) and G&A expenses of $20.7 million (up ~143% YoY), with cash used in operations at $0.6 million and liquidity of $164 million including $119.7 million cash on hand. Positively, TMC signed a commercial agreement with Allseas for a nodule collection system with 3.0 million wet tonnes per annum capacity, targeting Q4 2027 commissioning, and NOAA determined full compliance for TMC USA's consolidated exploration license and commercial recovery permit application for the 65,000 km² USA A project, expected to conclude by end-Q1 2027. These milestones support advancing offshore production and regulatory progress amid ongoing losses.

  • · TMC holds ~25% equity in TMCR, which has a 2.0% Gross Overriding Royalty on NORI area; TMC has right to repurchase up to 75% reducing TMCR's royalty to 0.5%.
  • · Nine American companies advancing 13 offshore mineral properties covering ~1.5 million km².
  • · TMC's S-K 1300 Technical Report Summaries include $5.5 billion NPV PFS declaring first nodule reserves.
AIM ImmunoTech Inc. 8-K neutral materiality 3/10

14-05-2026

AIM ImmunoTech Inc. filed an 8-K on May 14, 2026, furnishing a press release (Exhibit 99.1) dated May 14, 2026, related to a Virtual Investor Key Opinion Leader Connect segment featuring Professor Casper H.J. van Eijck, MD, PhD, from Erasmus Medical Center and consultant, and CEO Thomas K. Equels. A video of the segment was posted on the Virtual Investor website. The information is provided under Regulation FD Disclosure (Item 7.01) and not deemed filed.

INTELLIGENT BIO SOLUTIONS INC. 8-K mixed materiality 9/10

14-05-2026

Intelligent Bio Solutions Inc. reported fiscal Q3 2026 revenue of $1,060,802, up 46% YoY from $728,867, driven by cartridge sales growth of 59% to $703,538 (66% of revenue) and other sales up 80% to $217,857, though reader sales declined 16% to $139,407. Nine-month revenue reached $3,069,373, up 39% YoY from $2,208,648, with gross margins expanding to 50.5% in Q3 (from 46.8%) and 49.3% for the nine months (up 800 basis points). Despite revenue gains, Q3 net loss widened to $2,869,640 from $2,550,674, reflecting higher operating expenses.

  • · Cash and cash equivalents increased to $6,862,204 at March 31, 2026 from $740,371 at December 31, 2025.
  • · Total assets $14,862,792 at March 31, 2026, up from $8,249,786 at June 30, 2025.
  • · Q3 operating loss $2,947,101, wider than $2,560,329 YoY.
  • · Nine-month operating expenses $10,584,443, up from $8,917,114 YoY.
Muzinich BDC, Inc. 10-Q mixed materiality 7/10

14-05-2026

For the three months ended March 31, 2026, Muzinich BDC, Inc. reported total investment income of $3,372,623, down 38% YoY from $5,479,989, primarily due to sharp declines in affiliated investment income, alongside net unrealized depreciation of $1,520,722 compared to $150,939 appreciation YoY, resulting in net increase in net assets from operations of $1,053,568 versus $4,430,636 prior year. However, net investment income remained positive at $2,574,290, expenses fell 33% YoY to $798,333, net assets grew to $138,430,762 (up 0.8% QoQ from $137,377,194), and NAV per share rose to $818.63 from $812.40 QoQ. No stockholder distributions were made in the period, unlike $450,654 YoY.

  • · Aqua Leisure Recreation, LLC investments on non-accrual status, ceasing interest income recognition.
  • · Cash and cash equivalents increased to $5,198,100 from $3,605,909 QoQ.
  • · Credit facility borrowings increased to $80,250,000 from $77,850,000 QoQ.
  • · No dividends or distributions paid in Q1 2026 (vs $450,654 or $2.67 per share YoY).
  • · Several equity investments valued at $0 fair value, including Midwest Trading Group and QUEST JVCO.
NIQ Global Intelligence plc 10-Q mixed materiality 9/10

14-05-2026

NIQ reported Q1 2026 revenues of $1,072.7 million, up 11.1% YoY from $965.9 million, with strong growth in Americas (+13.6%) and EMEA (+13.2%), but APAC revenues declined slightly by 1.0%. Operating expenses increased to $1,082.9 million from $950.2 million, driven by higher restructuring ($64.9M vs $4.6M) and other costs, resulting in an operating loss of $10.2 million compared to a $15.7 million profit last year; net loss attributable to NIQ improved to $90.1 million from $119.8 million. Cash and equivalents fell to $362.3 million from $518.8 million at December 31, 2025, with net cash used in operating activities at $63.6 million versus $153.6 million prior year.

  • · Restructuring expenses $64.9M in Q1 2026 vs $4.6M in Q1 2025.
  • · Interest expense, net improved to $58.5M from $83.5M YoY.
  • · Total assets $6,749.3M as of March 31, 2026 vs $6,802.0M as of Dec 31, 2025.
  • · Long-term debt $3,473.5M as of March 31, 2026 vs $3,502.6M as of Dec 31, 2025.
  • · NIQ shareholders' equity $915.9M as of March 31, 2026 vs $988.4M as of Dec 31, 2025.
NIQ Global Intelligence plc 8-K mixed materiality 9/10

14-05-2026

NIQ reported strong Q1 2026 results exceeding expectations, with total revenue up 11.1% YoY to $1,072.7 million (5.1% OCC growth led by Americas at 9.3% OCC and EMEA at 4.6% OCC), Adjusted EBITDA up 19.1% to $224.8 million (margin expanded 150 bps to 21.0%), and significant improvements in net loss, Adjusted net income, and free cash flow. However, APAC revenue declined 1.0% reported (-3.6% OCC), and Americas Adjusted EBITDA margin was slightly down 10 bps to 28.3%. The company reaffirmed FY2026 guidance of 5.0%-5.3% OCC revenue growth, 23.5%-23.8% Adjusted EBITDA margin, and $235.0M-$250.0M levered free cash flow, while announcing a 2026 Restructuring Program targeting $70-$80 million annual cost savings.

  • · Landed 17 seven-figure wins including renewals, upsells, and competitive win-backs.
  • · eCommerce revenue growth accelerated to 33%; grew to 209 Full View Measurement clients.
  • · Selected by Ulta Beauty as primary beauty insights panel provider.
  • · 2026 Restructuring Program expected to incur $65-$75 million pre-tax charges, mostly cash.
  • · Cash paid for capital expenditures $59.6 million (5.6% of revenue) in Q1 2026 vs. $62.7 million (6.5%) in Q1 2025.
  • · Ongoing integration of AI expected to generate additional $70-$80 million annualized cost savings.
Iridium Communications Inc. 8-K positive materiality 10/10

14-05-2026

Iridium Communications Inc. (IRDM) entered a definitive agreement to acquire the remaining 61% equity interest in Aireon LLC for $366.7 million (50% at closing, 50% in one year), assuming approximately $155 million in debt, to integrate space-based ADS-B surveillance with its satellite network. The acquisition is accretive, expected to add at least $100 million in annualized service revenue and $30 million in OEBITDA, building on Aireon's 10% revenue CAGR over the past three years and extending partnerships with NAV CANADA and NATS through 2035. Post-closing, net leverage rises to 4.0x OEBITDA in Q3 2026 before returning to prior levels within 12 months, with no changes to Aireon's operations planned.

  • · Transaction targeted to close in early July 2026.
  • · Evercore (financial advisor), Cooley and Milbank (legal counsel) to Iridium; PJT Partners (financial advisor), Hogan Lovells (legal counsel) to Aireon.
  • · Iridium's long-term net leverage guide remains 2.0x OEBITDA by end of decade.
Intuitive Machines, Inc. 8-K mixed materiality 9/10

14-05-2026

Intuitive Machines reported record Q1 2026 revenue of $186.7 million, nearly 3x YoY, record positive Adjusted EBITDA of $2.7 million, and record backlog of $1.1 billion, driven by the $800 million Lanteris acquisition and new contracts including $428.9 million from SDA and $180.4 million CLPS task order. However, cash and equivalents declined sharply to $231.6 million from $582.6 million at year-end 2025, reflecting acquisition-related outflows and operations. Full-year 2026 revenue outlook is $900 million to $1 billion with positive Adjusted EBITDA.

  • · Total assets increased to $1.718 billion as of March 31, 2026 from $757.2 million at December 31, 2025, primarily due to Lanteris acquisition adding goodwill of $379.8 million and intangibles of $304.1 million.
  • · Signed definitive agreement in Q2 2026 to acquire Goonhilly Earth Station and COMSAT subsidiary.
  • · Contracted with U.S. Space Force under Andromeda IDIQ (ceiling $6.2 billion).
  • · Full-year 2026 Adjusted EBITDA expected positive.
CAMDEN ASSET MANAGEMENT L P /CA 13F-HR mixed materiality 6/10

14-05-2026

Camden Asset Management L P /CA filed its 13F-HR on May 14, 2026, reporting 69 holdings with a total market value of $2,941,647,409 as of March 31, 2026, primarily consisting of convertible notes in healthcare, technology, and energy companies. Quarter-over-quarter, the portfolio showed mixed performance with increases in Amphastar Pharmaceuticals (up 10.7% to $41.8M) and Alarm.com Holdings (up 8.6% to $20.5M). However, declines were prominent in NextEra Energy Capital (down 27.9% to $145.5M), ANI Pharmaceuticals (down 19.2% to $40.5M), and WEC Energy Group (down 17.0% to $145.6M).

  • · All reported positions held with sole investment discretion (SOLE).
  • · Portfolio focused on convertible debt securities (REG CNV), preferred stock (CVP), and limited common stock/warrants.
  • · BridgeBio Pharma Inc CV position declined 44.4% QoQ to $7.17M.
Mudita Advisors LLP 13F-HR neutral materiality 7/10

14-05-2026

Mudita Advisors LLP filed its 13F-HR on May 14, 2026, disclosing 28 equity holdings with a total market value of $490,065,486 as of March 31, 2026. The portfolio features significant exposure to mining and natural resources, with top positions including Hilton Grand Vacations Inc. ($108,702,979; 2,778,706 shares), IAMGOLD Corp. ($44,690,120; 2,375,300 shares), and Establishment Labs Holdings Inc. ($43,411,888; 764,563 shares). All holdings are reported with sole discretionary voting power.

  • · Other notable holdings: Canadian Nat Res Ltd ($25,942,195), Orla Mng Ltd ($21,247,644), Appian Corp ($20,237,935).
  • · Heavy concentration in mining/gold stocks including Alamos Gold Inc ($19,958,133), Hudbay Minerals Inc ($6,633,729), Kinross Gold Corp ($5,320,704).
  • · All 28 positions held with sole voting and disposition power (SH SOLE).
Federal Home Loan Bank of San Francisco 8-K neutral materiality 4/10

14-05-2026

The Federal Home Loan Bank of San Francisco reported the creation of a direct financial obligation via a consolidated obligation bond with a bank par amount of $15,000,000, traded on May 12, 2026, settling May 18, 2026, and maturing May 18, 2029. The bond carries a fixed constant coupon rate of 4.351% with next pay date and optional Bermudan call on November 18, 2026. This issuance is part of routine funding through capital markets, jointly backed by the eleven Federal Home Loan Banks but not guaranteed by the U.S. government.

  • · Trade date: May 12, 2026
  • · Settlement date: May 18, 2026
  • · Maturity date: May 18, 2029
  • · Next pay date: November 18, 2026
  • · Next call date: November 18, 2026
  • · Call type: Optional Principal Redemption
  • · Call style: Bermudan
  • · CUSIP: 3130BAQE0
SIMPLEX TRADING, LLC 13F-HR neutral materiality 9/10

14-05-2026

SIMPLEX TRADING, LLC filed its 13F-HR on May 14, 2026, disclosing holdings as of March 31, 2026, in approximately 10,161 positions with a total market value of $149.08 billion, predominantly call and put options on equities and ETFs. Top exposures include Apple Inc. call options ($2.22B, 8,760,100 shares equivalent) and put options ($1.53B, 6,022,900 shares equivalent), alongside smaller common stock positions such as 39,784 Apple shares ($10.1M). All positions reflect sole voting and disposition power, with no shared authority.

  • · All holdings reported with sole shared power for voting and disposition (0 for other managers).
  • · Portfolio heavily weighted toward options trading rather than long common stock positions.
  • · Former names: SET Trading Partners, LLC (changed 2012), Multiplex Trading LLC (changed 2010).
IMMUCELL CORP /DE/ 8-K positive materiality 9/10

14-05-2026

ImmuCell reported record Q1 2026 product sales of $10.4 million, up 28.4% YoY from $8.1 million, with gross margins expanding to 45.0% from 41.6% and net income rising to $1.9 million ($0.21 per share) from $1.4 million ($0.16 per share), driven by higher volumes and manufacturing efficiencies. The company generated $3.4 million in free cash flow, boosting cash to $6.8 million and net working capital to $14.9 million as of March 31, 2026. Management noted seasonal revenue moderation expected mid-year due to prior backorder clearance, with ongoing investments in sales and capacity expansion funded partly by a $2 million settlement from a former contract manufacturer.

  • · EBITDA increased to $2.6 million in Q1 2026 from $2.3 million in Q1 2025.
  • · Product development expenses decreased to $318 thousand from $757 thousand YoY.
  • · Sales, marketing and administrative expenses increased to $2.4 million from $1.5 million YoY.
  • · Conference call scheduled for May 15, 2026 at 9:00 AM ET.
MetaVia Inc. 10-Q mixed materiality 7/10

14-05-2026

MetaVia Inc. reported a net loss of $3,823 for Q1 2026, widening 4.1% YoY from $3,671, driven by a 23.5% increase in G&A expenses to $1,924 despite a 9.7% reduction in R&D expenses to $2,101. Cash and equivalents rose to $13,731 from $10,278 at year-end 2025, bolstered by $7,711 in net financing inflows from equity offerings that increased shares outstanding to 5.2 million from 2.3 million. Operating cash burn improved to $4,258 from $4,815 YoY.

  • · DA-1726 R&D costs: $1,447 in Q1 2026 vs. $1,479 in Q1 2025 (slight decline).
  • · Vanoglipel R&D costs: $167 in Q1 2026 vs. $291 in Q1 2025 (42.6% decline).
  • · Net cash provided by financing activities: $7,711 in Q1 2026 vs. $(12) in Q1 2025.
  • · Warrant liabilities decreased to $19 from $136.
Arcadia Biosciences, Inc. 10-Q mixed materiality 8/10

14-05-2026

Arcadia Biosciences reported Q1 2026 product revenues of $1.1M, down 8% YoY from $1.2M, while swinging to a net loss of $4.4M from a $2.6M profit in Q1 2025, driven by a $2.9M loss on the January 2026 Inducement Offer and $1.5M other loss. Cash and equivalents rose to $0.95M from $0.26M at Dec 31, 2025, bolstered by $1.8M net financing proceeds, though total assets declined 19% QoQ to $5.3M and stockholders' equity fell 30% to $2.9M. Operating cash use improved slightly to $1.1M from $1.6M YoY.

  • · Accounts receivable net of $559k allowance unchanged QoQ at $425k.
  • · Property and equipment net at $0 as of Mar 31, 2026, down from $8k.
  • · Common stock warrant and option liabilities increased to $1,073k from $347k.
  • · Weighted-average basic shares: 2,082,887 in Q1 2026 vs 1,366,060 in Q1 2025.
IMMUCELL CORP /DE/ 10-Q positive materiality 8/10

14-05-2026

ImmuCell Corp reported strong Q1 2026 results with product sales up 28% YoY to $10,357,295 and net income rising 34% to $1,941,607 (EPS $0.21 vs $0.16). Gross profit grew 39% YoY to $4,657,444, while operating expenses increased 20% YoY to $2,688,128 due to higher sales/marketing (+44%) and administrative expenses (+83%), though product development expenses declined 58%. Cash and equivalents surged to $6,812,637 (up 79% QoQ), driven by robust operating cash flow of $3,573,031 (up 127% YoY), with total assets at $44,108,374 and stockholders' equity at $29,135,040.

  • · Accumulated deficit improved to $(13,262,146) from $(15,203,753) QoQ.
  • · Debt obligations decreased to $8,702,266 total from $9,099,107 QoQ.
  • · Net cash used for investing activities $167,230 (improved from $329,050 YoY).
Aqua Metals, Inc. 8-K mixed materiality 7/10

14-05-2026

Aqua Metals reported Q1 2026 net loss of $3.95M, improved from $8.32M YoY due to lower operating expenses ($4.14M vs $8.68M), amid progress on commercialization including site selection for its first lithium battery recycling facility and technical milestones like battery-grade lithium carbonate production. Cash and equivalents declined 37% QoQ to $6.8M, with total assets down 13% to $17.1M. The company terminated its non-binding term sheet to acquire Lion Energy after due diligence, while maintaining active partnerships with 6K Energy and others.

  • · Provision for credit losses: $437K in Q1 2026
  • · Plant operations expense: $501K in Q1 2026 (down from $724K YoY)
  • · General and administrative expense: $2.92M in Q1 2026 (up from $2.38M YoY)
  • · Weighted average shares outstanding: 3,236,557 in Q1 2026 (up significantly from 809,571 in Q1 2025)
  • · Basic and diluted net loss per share: $(1.22) in Q1 2026 vs $(10.27) in Q1 2025
Arcadia Biosciences, Inc. 8-K mixed materiality 7/10

14-05-2026

Arcadia Biosciences reported Q1 2026 revenues of $1.1M, down 8% YoY from $1.2M, despite Zola coconut water volumes increasing 18% due to a prior-year revenue reserve release of $193k. SG&A expenses reached the lowest level in company history, decreasing $559k YoY, and gross proceeds of $2.1M were received from option exercises; however, operating expenses surged 180% to $1.9M without repeating prior one-time gains, resulting in a net loss of $4.4M or $2.11 per share versus $2.6M net income or $1.90 per share in Q1 2025.

  • · Cost of revenues increased $18k or 3% YoY due to higher Zola sales volume.
  • · Net loss per share was $2.11 in Q1 2026 vs net income per share of $1.90 in Q1 2025.
  • · Company requires additional funding in the near future to continue operations.
MetaVia Inc. 8-K mixed materiality 8/10

14-05-2026

MetaVia reported Q1 2026 net loss of $3.8M, widening slightly from $3.7M YoY, driven by higher G&A expenses of $1.9M (up 19% YoY) despite lower R&D of $2.1M (down 9% YoY), with total operating expenses up 3% to $4.0M. Cash position strengthened to $13.7M from $10.2M at year-end 2025, supported by $9.3M gross proceeds from January public offering, funding operations into Q4 2026. Clinical progress highlighted robust 9.1% weight loss in DA-1726 Phase 1 48mg cohort and first patient dosing in Part 3 titration study, with data expected Q4 2026.

  • · 48 granted and pending patents for vanoglipel providing protection into 2035.
  • · 39 granted and pending patents for DA-1726 providing protection through at least 2041.
  • · Data presentation on DA-1726 at EASL Congress 2026.
  • · End-of-Phase 2 meeting with FDA scheduled for vanoglipel in MASH.
Axiom Intelligence Acquisition Corp 1 10-Q mixed materiality 5/10

14-05-2026

Axiom Intelligence Acquisition Corp 1 reported net income of $1,520,809 for the three months ended March 31, 2026, driven by $1,795,775 in interest earned on investments held in the Trust Account, which grew to $206,030,469 from $204,234,694 at December 31, 2025. However, the company recorded an operating loss of $274,966 from general and administrative expenses, cash decreased to $545,146 (a 26% decline QoQ), and shareholders' deficit widened to $(7,459,246) from $(7,184,280). Total assets stood at $206,769,566 as of March 31, 2026.

  • · Redemption value increased to $10.30 per share as of March 31, 2026 from $10.21 as of December 31, 2025.
  • · Net cash used in operating activities: $191,134 for three months ended March 31, 2026.
  • · Deferred Fee remains at $8,000,000.
Inmune Bio, Inc. 8-K positive materiality 9/10

14-05-2026

INmune Bio Inc. (NASDAQ: INMB) announced that the U.S. FDA has granted Fast Track designation to XPro™ (pegipanermin), its first-in-class selective soluble TNF inhibitor, for the treatment of early Alzheimer’s disease, encompassing mild cognitive impairment (MCI) due to AD and mild Alzheimer’s disease dementia. This milestone facilitates more frequent FDA interactions, potential Rolling Review eligibility, and expedited development for a therapy targeting neuroinflammation, a key driver of early AD progression. The company is advancing a Phase 2b/3 seamless adaptive registrational trial in patients with inflammation biomarkers.

  • · Fast Track designation targets drugs for serious conditions with unmet medical needs, enabling more frequent FDA interactions and expedited review mechanisms.
  • · Phase 2b portion of trial uses EMACC and plasma pTau217 as decision-gating endpoints for advancement to Phase 3, which evaluates CDR-SB clinical outcomes.
  • · XPro™ selectively neutralizes soluble TNF (sTNF) while preserving transmembrane TNF and protective immune functions.
APPLIED MATERIALS INC /DE 8-K mixed materiality 9/10

14-05-2026

Applied Materials reported record Q2 FY2026 revenue of $7.91 billion, up 11% YoY, with GAAP gross margin expanding 0.8 points to 49.9% and record GAAP EPS of $3.51, up 33% YoY. Semiconductor Systems revenue grew to $5.97 billion (up ~10%) and Applied Global Services to $1.67 billion (up ~17%), but non-GAAP free cash flow declined 80% to $210 million and the Other segment swung to a $56 million operating loss from a $21 million profit. The company announced an agreement to acquire ASMPT's NEXX business and multiple EPIC Center partnerships to accelerate AI-related semiconductor innovations, with Q3 FY2026 outlook for revenue of ~$8.95 billion (+/- $500M) and non-GAAP EPS of $3.36 (+/- $0.20).

  • · Quarterly cash dividend increased 15% to $0.53 per share.
  • · Flash memory mix declined to 4% from 7% YoY in Semiconductor Systems.
  • · Received 2026 Intel EPIC Supplier Award for Excellence in Technology Development.
Aqua Metals, Inc. 10-Q mixed materiality 6/10

14-05-2026

Aqua Metals reported a net loss of $3,954 for the three months ended March 31, 2026, an improvement from $8,315 in the prior year period, primarily due to lower total operating expenses of $4,140 versus $8,683, with no impairment charges this year compared to $5,247 previously. However, cash and cash equivalents declined to $6,816 from $10,810 at December 31, 2025, reflecting net cash usage of $3,844 in operations (worse than $2,753 prior year) and $2,000 in investing activities for a note receivable to LION ENERGY. Stockholders' equity decreased to $13,126 from $14,770, amid ongoing losses and share issuances via ATM netting $1,295.

  • · Note receivable - LION ENERGY increased to $3,663 from $2,069.
  • · Provision for credit losses of $437 in Q1 2026.
  • · Basic and diluted net loss per share $(1.22) in Q1 2026 vs $(10.27) in Q1 2025.
  • · ATM share sales net proceeds $1,295 in Q1 2026.
  • · Potentially dilutive securities: 1,577,561 weighted average in Q1 2026.
FORMULA GROWTH LTD 13F-HR neutral materiality 6/10

14-05-2026

Formula Growth Ltd filed its 13F-HR on May 14, 2026, disclosing 137 equity positions with a total market value of $221,582,523 as of March 31, 2026. Largest holdings include Latham Group Inc (1,255,082 shares valued at $6,739,790), Stratasys Ltd (800,000 shares at $6,248,000), and Fox Factory Holding Corp (279,206 shares at $4,595,731). No prior period data is provided for comparison, and all positions reflect sole voting power.

  • · All reported holdings have sole voting power (SH SOLE) with zero shared power, performance shares, or put/call options.
  • · Filer CIK: 0001093219; SEC file number: 028-17511.
  • · Business address: 1010 Sherbrooke St W Suite 2300, Montreal A8 H3A 2R7.
INTELLINETICS, INC. 10-Q negative materiality 7/10

14-05-2026

Intellinetics, Inc. (INLX) reported Q1 2026 total revenues of $3,909,182, down 8% YoY from $4,247,345, driven by declines in professional services (-14.3% to $1,850,163) and software maintenance services (-11.6% to $296,393), while SaaS revenue was flat at $1,543,847 and storage services grew modestly 3.4% to $218,779. Gross profit fell 12.2% to $2,482,059 amid higher professional services costs, and operating expenses increased 4.4% to $3,664,611, widening the operating loss to $1,182,552 from $684,559. Net loss expanded to $1,177,853 ($0.27 per share) from $727,565 ($0.17 per share), with cash declining QoQ to $2,076,124 from $2,528,281 and total assets shrinking to $16,460,289 from $17,305,572.

  • · Net cash used in operating activities increased to $228,433 in Q1 2026 from $27,053 in Q1 2025.
  • · Stockholders’ equity decreased QoQ to $10,467,807 from $11,384,016.
  • · Deferred revenues declined to $2,901,457 from $3,371,263 QoQ.
INTELLINETICS, INC. 8-K mixed materiality 8/10

14-05-2026

Intellinetics reported first quarter 2026 total revenue of $3,909,182, down 8.0% YoY from $4,247,345, driven by a 14.3% decline in professional services revenue to $1,850,163, while SaaS revenue was nearly flat, up 0.1% to $1,543,847. Gross profit fell 12.2% to $2,482,059 with a 307 basis point margin contraction due to project mix, resulting in a net loss of $1,177,853 ($0.27 per share) versus $727,565 ($0.17 per share) in Q1 2025, exacerbated by $430,130 in non-recurring CEO transition costs. Adjusted EBITDA swung to a loss of $287,650 from a $76,589 profit, though management anticipates double-digit YoY SaaS growth for fiscal 2026.

  • · Software maintenance services revenue: $296,393 (down from $335,191 YoY).
  • · Storage and retrieval services revenue: $218,779 (up from $211,670 YoY).
  • · Total assets: $16,460,289 as of March 31, 2026 (down from $17,305,572 at Dec 31, 2025).
  • · Net cash used in operating activities: $228,434 in Q1 2026 (vs. $110,353 in Q1 2025).
  • · Conference call webcast at 4:30 p.m. ET on May 14, 2026.
Philadelphia Financial Management of San Francisco, LLC 13F-HR neutral materiality 5/10

14-05-2026

Philadelphia Financial Management of San Francisco, LLC filed a 13F-HR report disclosing total equity holdings valued at $345502942 as of March 31, 2026, across 43 positions primarily in financial services, insurance, banking, and related sectors. Top holdings by value include Goldman Sachs Group Inc (put options valued at $33416605 for 39500 shares), Axis Capital Holdings Ltd ($15008680 for 148000 shares), Target Hospitality Corp ($15002438 for 1616642 shares), HCI Group Inc ($14846116 for 96023 shares), and U S Gold Corp ($14731140 for 969792 shares). No prior period comparisons are available in this filing.

  • · All 43 holdings held with sole voting and disposition power (SOLE), except minor variations noted (e.g., Put for Goldman Sachs, some with 1,2,3 fair value method qualifiers).
  • · Portfolio includes smaller positions like LoanDepot Inc ($345061 value) and NI Holdings Inc ($190231 value).
  • · Related entities: Boathouse Row I, L.P. (CIK 0001458495), Boathouse Row II L P (CIK 0001295594), Boathouse Row Offshore Minyan, Ltd. (CIK 0001316058).
MORTON COMMUNITY BANK 13F-HR neutral materiality 4/10

14-05-2026

Morton Community Bank filed its 13F-HR report on May 14, 2026, disclosing a total portfolio value of $460,160,360 across 199 equity positions as of March 31, 2026. The holdings are diversified across common stocks in sectors including utilities (e.g., AT&T with 193,263 shares valued at $5,602,694 sole), energy (e.g., Chevron with 27,980 shares valued at $5,789,062 sole), technology (e.g., Cisco with 64,462 shares valued at $5,001,607 sole), and various ETFs such as iShares TR ($20,521,264 sole) and Schwab Strategic TR ($18,190,602 sole). This filing provides a snapshot with no period-over-period changes or performance metrics reported.

  • · Filing CIK: 0002011821
  • · SEC File Number: 028-23762
  • · Business address: 201 Clocktower Dr, East Peoria, IL 61611
  • · Phone: 309-407-3910
CADIZ INC 10-Q mixed materiality 7/10

14-05-2026

Cadiz Inc. reported Q1 2026 revenues of $1,632 thousand, down 45% YoY from $2,954 thousand, driven by declines in Land and Water Resources (37% to $358 thousand) and Water Filtration Technology (47% to $1,274 thousand). Operating loss narrowed 9% YoY to $6,835 thousand from $7,533 thousand, with net loss improving to $8,636 thousand from $9,593 thousand; however, cash used in operations worsened to $5,510 thousand from $3,644 thousand. Cash and equivalents rose to $16,535 thousand QoQ from $8,599 thousand, supported by $15,000 thousand in new long-term debt, though stockholders’ equity fell to $15,612 thousand from $23,256 thousand.

  • · General and administrative expenses decreased to $6,877 thousand from $8,107 thousand YoY.
  • · Derivative liabilities decreased to $2,557 thousand from $5,050 thousand QoQ.
  • · Net cash used in operating activities increased to $5,510 thousand from $3,644 thousand YoY.
  • · Weighted average shares outstanding increased to 83,516 thousand from 77,208 thousand YoY.
  • · Preferred stock dividend $1,288 thousand Q1 2026 vs $1,265 thousand Q1 2025.
MICROSOFT CORP 8-K positive materiality 7/10

14-05-2026

Microsoft Corp announced the appointment of Carmine Di Sibio, former global chairman and CEO of EY, to its board of directors effective May 14, 2026, expanding the board to 13 members. Di Sibio will serve on the Compensation Committee and Audit Committee, contributing expertise in financial services, risk oversight, and global leadership. The move was welcomed by lead independent director Sandra Peterson and CEO Satya Nadella for strengthening the board amid evolving customer needs.

  • · Di Sibio joined EY in 1985 and held roles including global managing partner in Client Services and chair of Global Financial Services Markets.
  • · Di Sibio holds a Bachelor of Arts in chemistry from Colgate University and an MBA from New York University’s Stern School of Business.
  • · Di Sibio also serves as independent director on boards of Hackensack Meridian Hospital, Colgate University, and Wake Forest University Business School.
FARADAY FUTURE INTELLIGENT ELECTRIC INC. 10-Q mixed materiality 8/10

14-05-2026

Faraday Future Intelligent Electric Inc. reported Q1 2026 revenue of $512 thousand, up 62% YoY from $316 thousand, with gross loss narrowing to $11.4 million from $21.1 million. However, net loss attributable to the company widened sharply to $38.9 million from $10.3 million YoY, amid $2.3 million in impairments, higher operating expenses, and a $31.5 million cash burn from operations. Cash and equivalents fell to $12.2 million from $34.9 million at December 31, 2025, while total assets declined 10% to $250.1 million.

  • · Impairment of intangible assets, including goodwill: $2,255 thousand in Q1 2026.
  • · Class A Common Stock shares increased by 83.3 million via conversions and issuances.
  • · Stockholders' equity improved to $19.2 million from $7.8 million QoQ.
  • · Net cash provided by financing activities: $7.8 million in Q1 2026.
PARADIGM CAPITAL MANAGEMENT INC/NY 13F-HR neutral materiality 7/10

14-05-2026

Paradigm Capital Management Inc/NY filed its 13F-HR on May 14, 2026, for the quarter ended March 31, 2026, disclosing 174 equity holdings with a total market value of $2,613,898,516. Largest positions include Modine Manufacturing Co ($298,105,843 sole), Fabrinet ($275,101,800 sole), Broadcom Ltd ($250,393,590 sole), and Jabil Inc ($140,916,715 sole). The filing reports both sole and defined voting authority shares across technology, healthcare, and industrials sectors, with no prior period comparisons provided.

  • · Investment adviser CIK: 000107982, SEC file number: 028-06298
  • · Reports holdings for investment adviser ID 801-47403 and 801-64574
  • · Business address: 9 Elk Street, Albany, NY 12207
COMTECH TELECOMMUNICATIONS CORP /DE/ 8-K neutral materiality 4/10

14-05-2026

Bruce T. Crawford resigned from Comtech Telecommunications Corp.'s Board of Directors, effective on or about June 15, 2026, to assume the role of president and Chief Executive Officer of AFCEA International. The resignation was not due to any disagreement with the Company or the Board. The Company expressed thanks for Mr. Crawford's dedication and years of service.

  • · Filing Date: May 14, 2026
  • · Date of earliest event reported: May 12, 2026
FARADAY FUTURE INTELLIGENT ELECTRIC INC. 8-K mixed materiality 8/10

14-05-2026

Faraday Future reported Q1 2026 revenue of $512,000, up 62% YoY from $316,000 and nearly matching full-year 2025 revenue of $536,000, driven by EAI robotics deliveries with positive gross margins, 68 units shipped by end-April (exceeding expectations), and a raised full-year shipment target of 1,500 units. Stockholders’ equity increased 148% to $19.2 million from Q4 2025 end, operating loss narrowed 18% YoY to $35.9 million, and G&A expenses declined 33% to $9.2 million. However, operating cash outflow rose 55% YoY to $31.5 million and total operating expenses increased to $24.5 million.

  • · SEC investigation concluded on March 18, 2026, with no penalties.
  • · Secured $45 million new financing from American institutional investors and $12 million subscription via revised agreement.
  • · Headquarters relocated to El Segundo, CA.
  • · Board appointed YT Jia as Global CEO and Jerry Wang as Global Executive Chairman; accepted Matthias Aydt’s resignation.
VERIZON COMMUNICATIONS INC 8-K positive materiality 8/10

14-05-2026

Verizon Communications Inc. closed the sale of $2,000,000,000 aggregate principal amount of its 6.050% Fixed-to-Fixed Rate Junior Subordinated Notes due 2058 and $2,000,000,000 aggregate principal amount of its 6.200% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056 on May 14, 2026. The notes were sold to a group of underwriters led by BNP Paribas Securities Corp., Goldman Sachs & Co. LLC, and others pursuant to an effective shelf registration statement on Form S-3 (Reg. No. 333-289928) effective August 29, 2025. This filing incorporates the forms of the global notes as exhibits to the registration statement.

  • · Notes sold pursuant to purchase agreement with listed underwriters acting as representatives.
  • · Registration Statement on Form S-3 (Reg. No. 333-289928) became effective upon filing on August 29, 2025.
  • · Exhibits 4.1 and 4.2: Forms of Global Notes for the respective notes.
MURPHY OIL CORP 8-K positive materiality 6/10

14-05-2026

Murphy Oil Corporation held its annual meeting of stockholders on May 13, 2026, where all 11 director nominees were elected with strong support (approval rates generally above 97%, though Jeffrey W. Nolan received the highest opposition at approximately 4 million against votes). Stockholders also approved the advisory vote on executive compensation, the 2026 Stock Plan for Non-Employee Directors, and the appointment of KPMG LLP as independent registered public accounting firm for 2026, all with over 97% approval. Broker non-votes totaled 12,483,996 shares across Proposals 1-3.

  • · Proposal 1 total participating votes approximately 119 million shares across directors.
  • · Proposal 4 had no broker non-votes and total votes of approximately 131.5 million shares.
  • · All proposals approved by management received majority support exceeding 95%.
QumulusAI, Inc. S-1/A neutral materiality 9/10

14-05-2026

QumulusAI, Inc. (QMLS) filed an S-1/A registration statement on May 14, 2026, disclosing board committee structures, risk oversight processes, and executive compensation details ahead of a direct listing on Nasdaq. For the year ended December 31, 2025, named executive officer total compensation varied, with CFO Scott Krosnowski receiving the highest at $392,750 including a $70,000 signing bonus and $136,250 bonus, while former CEO Robert C. Bissell's total declined 11% YoY to $218,000 from $245,500 in 2024, and SVP Houston Aderhold's increased 24% YoY to $218,000. New compensation agreements effective September 1, 2025, include substantial RSU grants such as $750,000 initial for CEO Michael Maniscalco and $975,810 special for SVP Patrick Gahan, alongside base salary increases tied to listing and market cap milestones.

  • · Board committees include Audit, Compensation, and Nominating and Corporate Governance, all meeting independence requirements.
  • · Nominating and Corporate Governance Committee oversees ESG activities and director diversity policies.
  • · Compensation agreements include non-compete provisions, severance (1-2x salary + accelerated equity vesting), and performance-based bonuses.
  • · Mr. Krosnowski part-time through January 15, 2025; Mr. Chatterjee joined post-TCM acquisition April 1, 2025.
  • · CEO base salary escalates to $400,000 upon $2B market cap post-listing.
Western Uranium & Vanadium Corp. 10-Q mixed materiality 6/10

14-05-2026

Western Uranium & Vanadium Corp. reported a narrowed net loss of $1,600,837 for Q1 2026, improved from $2,637,615 in Q1 2025, driven by a 39% reduction in operating expenses to $1,657,892 despite revenues declining 34% to $27,351. Cash and cash equivalents decreased QoQ to $4,552,637 from $5,620,630, with net cash used in operations improving to $1,043,509 from $2,186,106 YoY. Total assets stood at $33,127,792 as of March 31, 2026, down from $34,446,941 at year-end 2025.

  • · Stock-based compensation expense of $234,858 recognized in Q1 2026.
  • · Net cash used in investing activities minimal at $1,000 in Q1 2026 vs $166,507 in Q1 2025.
  • · Deferred tax liability unchanged at $2,708,887.
TMC the metals Co Inc. 10-Q mixed materiality 6/10

14-05-2026

TMC the metals Co Inc. reported a net loss of $20,599 thousand for the three months ended March 31, 2026, nearly unchanged YoY from $20,588 thousand despite operating expenses increasing 89% to $33,982 thousand, driven by G&A expenses surging 144% to $20,725 thousand and exploration expenses up 39% to $13,257 thousand. However, non-operating gains including a $10,662 thousand favorable change in warrant liability fair value and a $4,602 thousand gain on dilution of investment offset the higher costs. Cash balance rose slightly 2% QoQ to $119,682 thousand as of March 31, 2026 from $117,633 thousand at December 31, 2025, with net cash used in operations improving sharply to $615 thousand from $9,347 thousand YoY.

  • · Loss per share improved to $0.05 from $0.06 YoY.
  • · Equity improved to $(27,348) thousand from $(33,443) thousand QoQ.
  • · Investments increased to $15,052 thousand from $13,447 thousand QoQ.
  • · Accounts payable and accrued liabilities rose to $53,858 thousand from $46,048 thousand QoQ.
Blackstone Multi-Strategy Hedge Fund L.P. 10-Q neutral materiality 1/10

14-05-2026

Blackstone Multi-Strategy Hedge Fund L.P. reported total assets of $100 as of March 31, 2026, flat compared to $100 as of December 31, 2025. Cash and cash equivalents, net assets, and all other balance sheet items remained unchanged quarter-over-quarter at $100 with no liabilities recorded in either period.

  • · Filing date: May 14, 2026
  • · No liabilities, commitments, or contingencies reported as of March 31, 2026 or December 31, 2025
  • · General Partner Interest: $— (nil) in both periods
Welsbach Technology Metals Acquisition Corp. 8-K positive materiality 9/10

14-05-2026

Evolution Metals & Technologies Corp. (EM&T) entered into binding purchase orders with ULVAC Korea, Ltd. for thirteen high-performance rare earth sintered magnet making machines, expanding annual production capacity to 10,000 metric tons of rare earth magnets, including 6,000 metric tons of high-performance sintered magnets, with delivery and installation by November 2026. This positions EM&T as the world's largest producer of rare earth magnets outside China, leveraging a vertically integrated supply chain. No current financial metrics or declines were reported, though forward-looking statements note execution risks.

  • · Scheduled delivery and installation of all thirteen machines by November 2026.
  • · Standard ULVAC delivery timeline compressed from 24+ months.
  • · U.S. defense contractors required to buy American by January 2027.
  • · China’s April 2025 export controls on rare earth magnet materials noted as creating supply disruptions.
Alcosta Capital Management, Inc. 13F-HR neutral materiality 5/10

14-05-2026

Alcosta Capital Management, Inc. filed a 13F-HR report on May 14, 2026, disclosing total holdings of $131,214,636 across 23 positions as of March 31, 2026. Top holdings include NVIDIA Corporation ($20,104,832, 115,280 shares), Alphabet Inc. Cap Stk Cl C ($9,785,942, 34,114 shares), and Amazon.com Inc. ($9,767,446, 46,898 shares). No prior period data or performance changes are provided in this snapshot filing.

  • · Filing CIK: 0001842509
  • · Report period end: March 31, 2026
  • · Business address: 3180 CROW CANYON PL, SUITE 150, SAN RAMON, CA 94583
  • · All holdings reported as sole discretionary with zero put/call options
NATIONAL MUTUAL FUNDS MANAGEMENT LTD 13F-HR neutral materiality 4/10

14-05-2026

NATIONAL MUTUAL FUNDS MANAGEMENT LTD filed a 13F-HR combination report as of March 31, 2026, disclosing holdings in iShares Bitcoin Trust ETF (CUSIP 46438F101). The report details 207,468 shares valued at $5,400 thousand and 129,091 shares valued at $3,360 thousand, for a total of 336,559 shares worth $8,760 thousand. No period-over-period changes are reported in the filing.

  • · Filing submitted on May 14, 2026, for period ending March 31, 2026.
  • · Filer address: 50 Bridge Street, Sydney NSW 2000, Australia.
  • · 13F file number: 028-23268.
TIMUCUAN ASSET MANAGEMENT INC/FL 13F-HR neutral materiality 7/10

14-05-2026

Timucuan Asset Management Inc/FL filed its Form 13F-HR on May 14, 2026, disclosing total holdings of $2,717,098,993 across 28 equity positions as of March 31, 2026. Top positions by market value include Charles Schwab Corporation ($277,145,767), Installed Building Products Inc ($219,243,785), SomniGroup International ($217,445,419), Analog Devices Inc ($216,290,472), and Booking Holdings Inc ($199,347,057), with all holdings reported as sole discretionary. No prior period data is provided in the filing for comparison.

  • · All positions reported as SH SOLE with 0 shares for other managers, puts, and calls
  • · Smaller positions include German American Bancorp (15,000 shares, $626,850), IES Holdings (5,000 shares, $2,382,350), and Kimberly-Clark Corp (5,000 shares, $482,350)
  • · Report period end: March 31, 2026; Filed as of: May 14, 2026
Trilogy Metals Inc. 8-K mixed materiality 6/10

14-05-2026

At its Annual Meeting on May 14, 2026, Trilogy Metals Inc. shareholders elected seven director nominees to the Board for one-year terms, approved the appointment of PricewaterhouseCoopers LLP as independent auditors, and approved executive compensation on a non-binding advisory basis. While all proposals passed, five director nominees received significant withheld votes exceeding 9.9 million shares each (up to 10.6 million for William Iggiagruk Hensley), compared to 61-72 million 'For' votes, signaling notable shareholder dissent. Auditor approval was overwhelming with 108 million 'For' votes and minimal opposition.

  • · Two director nominees (Tony Giardini and James Gowans) received over 71 million 'For' votes with minimal withheld (under 554k).
  • · Broker non-votes totaled 36,096,020 shares across director elections and 36,096,022 for executive compensation.
  • · No abstentions recorded for director elections or auditor appointment.
Risk Paradigm Group, LLC 13F-HR neutral materiality 4/10

14-05-2026

Risk Paradigm Group, LLC filed its quarterly 13F-HR report on May 14, 2026, for the period ended March 31, 2026, disclosing 59 equity positions held with sole discretionary authority and a total market value of $117,222,697. The portfolio consists primarily of ETFs from providers such as iShares, SPDR, and First Trust, spanning sectors like fixed income, equities, commodities, and international markets. No changes in holdings or performance metrics are detailed in this snapshot filing.

  • · All 59 positions held with sole voting authority (SH SOLE)
  • · No shared or other discretionary holdings reported
  • · Business address: 25 Burlington Mall Rd, Suite 404, Burlington, MA 01803
  • · SEC file number: 028-16891
Arcadia Wealth Management, Inc. 13F-HR neutral materiality 6/10

14-05-2026

Arcadia Wealth Management, Inc. filed its 13F-HR report for the quarter ended March 31, 2026, disclosing a total portfolio value of $184785682 across 55 equity positions, all held with sole voting and dispositive power. Top holdings include American Centy ETF TR US EQT ETF valued at $39943491 (359269 shares), Dimensional ETF Trust US Core Equity 2 at $37043889 (953265 shares), and Dimensional ETF Trust US Real Estate E at $4363065 (184485 shares). No prior period comparisons or changes in holdings are provided in the filing.

  • · All 55 positions held with sole voting power (SH SOLE) and no shared power reported.
  • · Report filed on May 14, 2026, for period ending March 31, 2026.
  • · Business address: 10 Edgewood Avenue, Smithtown, NY 11787.
Marathon Trading Investment Management LLC 13F-HR neutral materiality 8/10

14-05-2026

Marathon Trading Investment Management LLC reported 389 holdings totaling $3,671,982,429 as of March 31, 2026, in its 13F-HR filing submitted on May 14, 2026. The portfolio emphasizes options contracts on ETFs (e.g., iShares Bitcoin Trust with $97.8M put options OTR, iShares Silver Trust with $333.9M put options OTR) alongside common stocks in tech (Microsoft 200,002 shares SOLE), crypto/mining (MARA Holdings 369,300 shares SOLE, Core Scientific 13,160 shares SOLE), and meme stocks (Beyond Meat 2,058,540 shares OTR). No prior period data is provided for comparison.

  • · Business address: Four Radnor Corporate Center, Suite 255, Radnor, PA 19087
  • · SEC file number: 028-16519
  • · Significant options exposure including 2,544,600 Put shares OTR on iShares Bitcoin Trust ETF and 4,899,800 Put shares OTR on iShares Silver TR
  • · Holdings include 200,002 shares SOLE Microsoft Corp valued at $74.0M

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 48 filings

More from: Nasdaq 100 Stocks SEC Filings

🇺🇸 More from United States

View all →